l-(?,3-Epoxy-5-0-trityl-B-D-lyxofuranosyl)uracn (1) was treated with a number of carbon nucTeophiles. Ethynyl lithium gave 3'-deoxy-3'-ethynyl-5'-0-trityl-ara-uridine (2), which was reduced to the corresponding 3'-ethenyl c ompound (4). Sodium cyanide gave 3'-cyano-3'-deoxy-5'-0-trityl-ara-ur1d1ne (11) which upon alkaline hydrolysis gave the corresponding 3'-carboxamido compound (13). l,3-Dithian-2-yl lithium gave 3'-deoxy-3'-(l,3-d1thian-2-yI)-5'-0-trityl-ara-uridine (14). The trityl group was removed from each of these compounds by mild acidic hydrolysis. Treatment of 2 with 0.1M H-SO. and mercury (II) acetate afforded 3'-acetyl-3'-deoxy-ara-uridine (6) which upon reduction with NaBH. gave 3'-deoxy-3'-(l-hydroxyethan-l-yl)-ara-urid1ne (7). Acetylation of 6 yielded 5'-£-acetyl-3'-acetyl-2',3'-didehydro-2' ,3'-dideoxyuridine (8) which upon reduction with NaBH. produced a mixture of 5'-0-acetyl-2',3 l -d1dehydro-2 l ,3'-d1deoxy-3 l -(l-hydroxyethan-l-yl)ur1d1ne (9) and" l-(Rj[5-(S)-acetoxymethyl-4-(l-hydroxyethan-l-yl)-tetrahydrofuran-2-yl]-uraci I (ITT). Reduction of 14 with Raney nickel followed by removal of the trityl group gave 3'-deoxy-3'-methyl-ara-uridine (16).
INTRODUCTION
Numerous analogues of nucleosides have been synthesised and some of them have been found to be potent antiviral and antineoplastic agents. These analogues are nucleosides which contain modifications in either the sugar residue or the base residue and sometimes both. In some of these analogues the modification consists of a branching of the carbon chain of the sugar residue. Compounds of this type have usually been obtained by synthesising the branched-chain sugar and then condensing it with the pyrimidine or purine 4-7 base. This is a lengthy and tedious procedure. Recently, however, the synthesis of branched-chain sugar nucleosides by a shorter procedure, namely treatment of l-(5-0-tr1tyl-2',3'-epoxy-^-D-lyxofuranosyl)urac1I (1) with some carbon nucleophiles has been reported by Mete The ethyne, 2 reacted with mercury (II) acetate and sulphuric acid to give 3'-acetyl-3'-deoxy-ara-uridine (6) which upon reduction with sodium borohydride gave 3'-deoxy-3'-(l-hydroxyethan-l-yl)-ara-uridine (7) as a mixture of diastereomers. The n.m.r. spectrum of 6 contained a sharp singlet at 6 2.25 due to the methyl group. The spectrum of 7 clearly showed the presence of two diastereomers (present in about equal amounts) because there were present two pairs of resonances, clearly separated for H-l 1 , H-6, 0H-2 1 and -CH0HCH 3 . An attempt was made to acetylate the two hydroxyl groups of 6 with acetic anhydride in pyridine. However, the n.m.r. spectrum of the product contained only two methyl resonances, the anomeric proton and the 2'-proton resonances were complex and appeared downfield (from those of 6) at 6 6.95 and 6.65 respectively and there was no signal for a proton at C-3 1 (14), which upon treatment with acid gave the detrityiated compound (15). Reduction of 14 with Raney nickel followed by removal of the trityl group gave 3'-deoxy-3'-methyI-arauridine (16). The assignment of the structures to compounds 14-16 was based upon elemental analysis and n.m.r. spectroscopy.
None of the compounds showed significant antiviral or antitumour activity, which is not surprising because uracil derivatives rarely do. However, the methods used should be applicable to some 5-substituted uracil derivatives and to other nucleosides which might be expected to be active and work is proceeding on these. 3'-Deoxy-3'-ethyny1-5'-0-tr1tyl-ara-uridine (2) . The ethylenediamine complex of ethynyl lithium (3.54 g, 34.6 mmole, 90* pure) was added to dimethyl sulphoxide (50 ml) and the dark-brown suspension stirred for 1 h at 20°C. The suspension was filtered in an atmosphere of dry nitrogen and to the clear filtrate there was added compound 1 (6.0 g, 12.8 mmole) and the mixture stirred at~20°C for 4P h. It was then poured into ice-water (500 ml) and the pH adjusted to 7 with 1M hydrochloric add. The resulting brown solid was filtered off and retained. The filtrate was extracted with ethyl acetate and the ethyl acetate layer evaporated to dryness to give a brown solid. The two solids were combined and purified by column chromatography using tolueneacetone (7:4) as the eluant. This gave an off-white solid which was further purified by the use of a second column to give the product as a white solid (4). To a solution of compound 2 (1 g, 2.0 mmole) in ethanol there was added Undlar's catalyst (0.2 g) and the resulting suspension stirred vigorously and hydrogenated at -20° C. When the uptake of hydrogen and examination by t.l.c. showed that the starting material had been completely converted into another compound, the catalyst was filtered off and the filtrate evaporated to dryness to give a white solid (1.0 g) which was crystallised from aqueous ethanol to give the product (Found: C, 72.5; H, 5.4; N, 5.8. Calc. for C 3O Reduction of compound 8 with sodium borohydride. Compound 8 (100 mg, 0.34 mmole) was dissolved in ethanoi (5 ml) and sodium borohydride (25.7 mg, 0.68 mmole) added. After 45 m1n. at~20°C examination by t.l.c. showed that no starting material remained and two slower-running components had been formed. The reaction mixture was neutralised with 1M hydrochloric acid, evaporated to dryness and the residue fractionated by column chromatography using chloroform-ethano I (9:1) as the eluant. The first product e luted (29 mg, 3035 yield) was l-(R) 3'-Cyano-3'-deoxy-5'-0-trityl-ara-uridine (11). To a solution of compound 1 (2.0 g, 4.3 mmole) in dimethylsulphoxide (40 ml), there was added sodium cyanide (1.0 g, 20.4 mmole) and the resulting suspension stirred at 47°C for 8 h. The resulting dark mixture was poured into water (600 ml) and neutralised with 1M hydrochloric acid. The resulting brown solid was filtered off and dissolved in ethyl acetate. The ethyl acetate solution was washed twice with water and the solvent removed by evaporation. The brown residue was fractionated by column chromatography using toluene-ethyl acetate (7:4) as the eluant. 3'-Carboxamido-3'-deoxy-5'-0-trityl-ara-uridine (13). To a solution of 11 (250 mg, 0.50 mmole) in aqueous methanol (20 ml) there was added hydrogen peroxide (30*, 0.4 ml) and potassium carbonate (140 mg) and the reaction mixture heated at 43°C for 6 days. The solvent was removed by evaporation and the residue purified by column chromatography using chloroform-ethanol 3'-Deoxy-3'-(l,3-dithian-2-yl)-5'-0-tr1tyl-ara-uridine (14). To a solution of freshly-purified 1,3-dithiane (2.5 g, 20.8 mmole) in tetrahydrofuran (25 ml) there was added hexamethylphosphoramide (4 ml). The apparatus was purged with dry nitrogen and the reaction carried out under dry nitrogen. The solution was cooled to -4O°C and butyl lithium in hexane (14.7 ml of 1.55M) added at the rate of 4 ml/min. The mixture was kept at -4n°C for 2 h and then it was added dropwise to a solution of compound 1 (2.43 g, 5.1 Q mmoles) in tetrahydrofuran (10 ml) and hexamethylphosphoramide (14 ml) at -40°C. After 2 h the reaction mixture was allowed to warm to room temperature and poured into water (400 ml). The solution was neutralised with 1M hydrochloric acid and extracted with ethyl acetate. The ethyl acetate extract was dried and evaporated to dryness to give a yellow solid which was purified by column chromatography using toluene-acetone (7:^) as the eluant. The appropriate fractions were collected and evaporated to dryness to give a white solid (1.77 g, 581! yield) which was crystallised from aqueous ethanol to give the product (Found: C, 64. 
